EXACTA · UNITED STATES
Evidence hub
Read the study design and limitations alongside the results.
These summaries cover the five papers linked by the existing Exacta publications page. They describe published research, not a promise of benefit or a treatment recommendation.
RESILIENT trial
Nagarkar R and colleagues • Oncotarget • 2019
mTOR pathway combination study
Crook T and colleagues • Frontiers in Pharmacology • 2021
Angiogenesis inhibitor combination study
Crook T and colleagues • Frontiers in Molecular Medicine • 2021
Circulating tumor-associated cell drug-response study
Crook T and colleagues • Cancer Chemotherapy and Pharmacology • online 2020; volume 2021
LIQUID IMPACT pilot study
Patil D and colleagues • Frontiers in Oncology • 2022
Publication authors are credited on each summary. Attribution does not imply that they have reviewed this website.